Peer-reviewedCC BY-NC-NDTranslational cancer research
Efficacy and safety of antibody-drug conjugates in advanced small cell lung cancer: a systematic review and single-arm meta-analysis of prospective clinical trials
Related
- Efficacy and safety of antibody-drug conjugates in pretreated HER2-positive advanced breast cancer: a network meta-analysis of randomized controlled trials
- Intracranial Activity of Deruxtecan-Based Antibody–Drug Conjugates in Non-Small Cell Lung Cancer Brain Metastases: A Systematic Review and Meta-Analysis of Prospective Trial Cohorts
- Efficacy and safety of antibody–drug conjugates in EGFR-mutated non-small cell lung cancer after EGFR-TKI resistance: a systematic review and meta-analysis
- Antibody–drug conjugates in advanced small-cell lung cancer: a systematic review and single-arm meta-analysis of later-line monotherapy
- Antibody–Drug Conjugates Plus Immune Checkpoint Inhibitors for Sustained Disease Control in Advanced Solid Tumors
BibTeX
@article{anon2026efficacy,
title = {{Efficacy and safety of antibody-drug conjugates in advanced small cell lung cancer: a systematic review and single-arm meta-analysis of prospective clinical trials}},
journal = {Translational cancer research},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13657816},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Efficacy and safety of antibody-drug conjugates in advanced small cell lung cancer: a systematic review and single-arm meta-analysis of prospective clinical trials
PY - 2026
DA - 2026/08/28
JO - Translational cancer research
UR - https://europepmc.org/article/PMC/PMC13657816
SN - 2218-676X
ER -